%D8%AA%D8%A7%D9%85%D9%88%D9%83%D8%B3%D9%8A%D9%81%D9%8A%D9%86%D8%AA%D8%A7%D9%85%D9%88%DA%A9%D8%B3%DB%8C%D9%81%D9%86Category:TamoxifenTamoxifenTamocsiffenTamoxifenTamoxifenTamoxifeno%D8%AA%D8%A7%D9%85%D9%88%DA%A9%D8%B3%DB%8C%D9%81%D9%86TamoksifeeniTamoxif%C3%A8neTamocsaifeinTamoxifeno%D7%98%D7%9E%D7%95%D7%A7%D7%A1%D7%99%D7%A4%D7%9FTamoksifenTamoxifene%E3%82%BF%E3%83%A2%E3%82%AD%E3%82%B7%E3%83%95%E3%82%A7%E3%83%B3%ED%83%80%EB%AA%A9%EC%8B%9C%ED%8E%9CTamoxifenumTamoksifenas%D0%A2%D0%B0%D0%BC%D0%BE%D0%BA%D1%81%D0%B8%D1%84%D0%B5%D0%BDTamoxifen%E0%AC%9F%E0%AC%BE%E0%AC%AE%E0%AD%8B%E0%AC%95%E0%AD%8D%E0%AC%B8%E0%AC%BF%E0%AC%AB%E0%AD%87%E0%AC%A8TamoksyfenTamoxifenoTamoxifen%D0%A2%D0%B0%D0%BC%D0%BE%D0%BA%D1%81%D0%B8%D1%84%D0%B5%D0%BDTamoksifenTamoksifenTamoksifen%E0%B8%97%E0%B8%B2%E0%B8%A1%E0%B9%87%E0%B8%AD%E0%B8%81%E0%B8%8B%E0%B8%B4%E0%B9%80%E0%B8%9F%E0%B8%99Tamoksifen%D0%A2%D0%B0%D0%BC%D0%BE%D0%BA%D1%81%D0%B8%D1%84%D0%B5%D0%BDTamoxifenQ412178%E8%AB%BE%E7%93%A6%E5%BE%97%E5%A3%AB
about
P1056
P1855
P3781
Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer PatientsChemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.Casodex - Nolvadex CombinationRadiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant GliomasSorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III MelanomaSunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular MelanomaLapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast CancerTamoxifen Compared With Clomiphene Citrate for Women Who Had Thin Endometrium Women Under Clomiphene in a Previous CycleBone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98Phase II Trial of SAHA & Tamoxifen for Patients With Breast CancerStudy of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 PolymorphismsNeoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer PatientsPAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast CancerFirst-in-Human Dose Escalation Trial in Subjects With Advanced MalignanciesEfficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for BrachytherapyAnalgesic Efficacy of Pulsed Radiofrequency in Non-cyclic MastalgiaA Study of Flibanserin in Breast Cancer Survivors on TamoxifenRadiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone MetastasisTamoxifen and Bortezomib to Treat Recurrent Brain TumorsTamoxifen in Treating Patients With Primary Liver CancerRadiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast CancerHigh-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast CancerTamoxifen in Treating Women With High-Risk Breast CancerHormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast CancerEffect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast CancerChemoprevention Therapy Plus Surgery in Treating Women With Breast CancerTamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast CancerEffect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal WomenHormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast CancerChemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2Adjuvant Hormone Therapy in Treating Women With Operable Breast CancerChemotherapy in Treating Women With Breast Cancer That Can Be Surgically RemovedSafety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase InhibitorEndocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast CancerPre-operative Hormonal Treatment for Hormone Receptor Positive Breast CancerAdjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine TreatmentFeasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or NotAdjuvant AI Combined With ZoladexTrial of Low Dose Tamoxifen in Women With Breast Intraepithelial NeoplasiaUse of Tamoxifen in Systemic Mastocytosis
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Tamocsaifein
@ga
Tamoksifen
@id
Tamoksifen
@sh
Tamoksifen
@sl
Tamoksifen
@sr-el
Tamoksifen
@tr
Tamoksifenas
@lt
Tamoksyfen
@pl
Tamoxifen
@cs
Tamoxifen
@de
type
label
Tamocsaifein
@ga
Tamoksifen
@id
Tamoksifen
@sh
Tamoksifen
@sl
Tamoksifen
@sr-el
Tamoksifen
@tr
Tamoksifenas
@lt
Tamoksyfen
@pl
Tamoxifen
@cs
Tamoxifen
@de
altLabel
(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine
@en
(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine
@en
1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
@en
1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
@en
10540-29-1
@fr
C26H29NO
@fr
C26H29NO
@sr
Citrato de tamoxifeno
@pt
ICI-46474
@cy
ICI-46474
@en
prefLabel
Tamocsaifein
@ga
Tamoksifen
@id
Tamoksifen
@sh
Tamoksifen
@sl
Tamoksifen
@sr-el
Tamoksifen
@tr
Tamoksifenas
@lt
Tamoksyfen
@pl
Tamoxifen
@cs
Tamoxifen
@de